De-activating chromosomes to prevent cancer
21 Jul 2015
De-activating chromosomes to prevent cancer
New emerging treatments in multiple myeloma
Natural killer immunity and the cancer immunome
What can T-cells see on human cancer?
Moving precision medicine for lung cancer into the adjuvant setting
WIN Symposium 2015 highlights
Radiation and immunology – a new therapeutic partnership
TAT 2016: Targeted anticancer therapies
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Exciting update on the Repurposing Drugs in Oncology (ReDO) project
EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM